ArticleNature communications2021

Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients.

Linlin Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.